Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment

Abstract

To better understand genetic alterations in oral premalignant lesions, we examined 84 oral leukoplakia samples from 37 patients who had been enrolled in a chemoprevention trial. The samples were analyzed for two microsatellite markers located at chromosomes 9p21 and 3p14. Loss of heterozygosity (LOH) at either or both loci was identified in 19 of the 37 (51%) patients. Of these 19 patients, seven (37%) have developed head and neck squamous cell carcinoma (HNSCC) while only one of 18 (6%) of patients without LOH developed HNSCC. Our data suggest that clonal genetic alterations are common in oral premalignant lesions; that multiple genetic alterations have already occurred in oral premalignant lesions, allowing at least a focal clonal expansion; and that losses of the 9p21 and 3p14 regions may be related to early processes of tumorigenesis in HNSCC. These genetic alterations in premalignant tissues may serve as markers for cancer risk assessment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Silverman, S., Jr., Gorsky, M. & Lozada, F. Oral leukoplakia and malignant transformation: A follow-up study of 257 patients. Cancer 53, 563–568 (1984).

    Article  PubMed  Google Scholar 

  2. Bánóczy, J. & Csiba, A. Comparative study of the clinical picture and histopathologic structure of oral leukoplakia. Cancer 29, 1230–1234 (1972).

    Article  PubMed  Google Scholar 

  3. Lippman, S.M. et al. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N. Engl. J. Med. 328, 15–20 (1993).

    Article  CAS  PubMed  Google Scholar 

  4. Hong, W.K. et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med. 153, 1501–1505 (1986).

    Article  Google Scholar 

  5. Silverman, S., Jr., Gorsky, M. & Lozada, F. Oral leukoplakia and malignant transformation. Cancer 53, 563–568 (1984).

    Article  PubMed  Google Scholar 

  6. Sidransky, D. Molecular genetics of head and neck cancer. Curr. Opin. Oncol. 7, 229–233 (1995).

    Article  CAS  PubMed  Google Scholar 

  7. Field, J.K. et al. Allelotype of squamous cell carcinoma of the head and neck: Fractional allele loss correlates with survival. Br. J. Cancer 72, 1180–1188 (1995).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Nawroz, H. et al. Allelotype of head and neck squamous cell carcinoma. Cancer Res. 54, 1152–1155 (1994).

    CAS  PubMed  Google Scholar 

  9. van der Riet, P. et al. Frequent loss of chromosome 9p21–22 early in head and neck cancer progression. Cancer Res. 54, 1156–1158 (1994).

    CAS  PubMed  Google Scholar 

  10. Cairns, P. et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nature Genet. 11, 210–212 (1995).

    Article  CAS  PubMed  Google Scholar 

  11. Nobori, T. et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753–756 (1994).

    Article  CAS  PubMed  Google Scholar 

  12. Zhang, S. et al. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res. 54, 5050–5053 (1994).

    CAS  PubMed  Google Scholar 

  13. Merlo, A. et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med. 1, 686–692 (1995).

    Article  CAS  PubMed  Google Scholar 

  14. Naylor, S.L., Johnson, B.E., Minna, J.D. & Sakaguchi, A.Y. Loss of heterozygosity of chromosome 3p in small-cell lung cancer. Nature 329, 451–454 (1987).

    Article  CAS  PubMed  Google Scholar 

  15. Maestro, R. et al. Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res. 53, 5775–5779 (1993).

    CAS  PubMed  Google Scholar 

  16. Ohta, M. et al. The FHIT gene, spanning the chromosome 3pl4.2 fragile site and renal carcinoma associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84, 587–597 (1996).

    Article  CAS  PubMed  Google Scholar 

  17. Kishimoto, Y. et al. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J. Natl. Cancer Inst. 87, 1224–1229 (1995).

    Article  CAS  PubMed  Google Scholar 

  18. Hung, J. et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J. Am. Med. Assoc. 273, 558–563 (1995).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mao, L., Lee, J., Fan, Y. et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 2, 682–685 (1996). https://doi.org/10.1038/nm0696-682

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0696-682

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing